35 results on '"Aisaka, Yasuyuki"'
Search Results
2. Analysis of Lenvatinib’s Efficacy against Intermediate-Stage Unresectable Hepatocellular Carcinoma
3. Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma
4. Effect of prolonged administration of pegylated interferon/ribavirin therapy in genotypes 2a and 2b: Propensity score-matched analysis
5. Efficacy of Lusutrombopag for Thrombocytopenia in Patients with Chronic Liver Disease Scheduled to Undergo Invasive Procedures
6. Clinical Outcomes of 2nd- and 3rd-Line Regorafenib for Advanced Hepatocellular Carcinoma
7. Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma
8. Self-expandable Metallic Stent for Obstructive Colorectal Cancer in Our Hospital: Evaluation of Short-term Benefit
9. Impact of ribavirin dose reduction on the efficacy of pegylated interferon plus ribavirin combination therapy for elderly patients infected with genotype 1b and high viral loads
10. Real‐world efficacy of sofosbuvir plus velpatasvir therapy for patients with hepatitis C virus‐related decompensated cirrhosis
11. Analysis of Post-Progression Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib
12. Predicting the response to 48-week combination therapy with peginterferon α-2b plus ribavirin from the estimated HCV RNA load index after negative serum change in genotype 1b hepatitis C patients
13. Serum HBV RNA is a predictor of early emergence of the YMDD mutant in patients treated with lamivudine
14. Overlooked muscle cramps in patients with chronic liver disease: in relation to the prevalence of muscle cramps
15. Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status
16. Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis
17. A case of dual oral therapy for elderly patients with acute hepatitis C
18. Overlooked muscle cramps in patients with chronic liver disease: in relation to the prevalence of muscle cramps.
19. Characteristics of Extrahepatic Second Primary Malignancies after Hepatectomy for Hepatocellular Carcinoma in Japan
20. S1904 Assessment of the Liver Function of the NaïVE Patient With Hepatocellular Carcinoma Over 80 Years Old
21. W1794 Assessment of the Development of Hepatocellular Carcinoma in the Hepatitis C Virus Eradicated Patients After Interferon Therapy
22. Histological findings and interferon treatment outcomes in patients with normal ALT levels and high viral load of HCV genotype 2
23. Prolonged Negative HCV-RNA Status Led to a Good Outcome in Chronic Hepatitis C Patients with Genotype 1b and Super-High Viral Load
24. A case of primary biliary cirrhosis with systemic lymph node enlargement
25. Immune-mediated Cholangiohepatitis in Neonatally Thymectomized Mice: the Role of T Cells and Analysis of T-Cell Receptor Vβ Usage
26. A case of drug-induced chronic hepatitis
27. Recovery from acute cholestasis associated with erythropoietic protoporphyria treated by antibiotics
28. A case of jevenile primary biliary cirrhosis with remarkable enlarged lymphnodes.
29. A case of latent primary biliary cirrhosis
30. Outcomes of Patients with Child-Pugh B and Unresectable Hepatocellular Carcinoma Undergoing First-Line Systemic Treatment with Sorafenib, Lenvatinib, or Atezolizumab Plus Bevacizumab.
31. [Multiple hepatic sclerosed hemangiomas that are difficult to diagnose preoperatively:a case report].
32. Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy and Sorafenib in Patients with Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization.
33. Hepatitis C virus (HCV) reactivation caused by steroid therapy for dermatomyositis.
34. Second hepatectomy for recurrent hepatocellular carcinoma achieved sustained virological response to interferon therapy for hepatitis C.
35. Predicting the response to 48-week combination therapy with peginterferon alpha-2b plus ribavirin from the estimated HCV RNA load index after negative serum change in genotype 1b hepatitis C patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.